{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:35:59Z","timestamp":1792881359416,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    KDM5A is a critical chromatin-modifying enzyme with lysine-specific demethylase activity and is highly expressed in brain tissues. Biallelic pathogenic variants in\n                    <jats:italic>KDM5A<\/jats:italic>\n                    are linked to\n                    <jats:italic>KDM5A<\/jats:italic>\n                    -related neurodevelopmental disorders, a rare disorder involving significant cognitive and motor impairments. We conducted a clinical and genetic evaluation of a patient with severe neurodevelopmental delay. Exome sequencing was performed to identify the genetic aetiology, followed by quantitative expression analysis to assess the functional impact of the identified variant on\n                    <jats:italic>KDM5A<\/jats:italic>\n                    mRNA levels. A novel homozygous\n                    <jats:italic>KDM5A<\/jats:italic>\n                    c.2836\u2009C\u2009&gt;\u2009T p.(Gln946Ter) variant was identified in the proband. Quantitative analysis showed a reduction in\n                    <jats:italic>KDM5A<\/jats:italic>\n                    expression. However, this decrease was not statistically significant. The patients displayed neuromotor developmental delay, severe axial hypotonia, absence of head control and mild upper-extremity spasticity. Additional findings included a history of seizures, facial dysmorphism and congenital heart disease. These findings expand the known clinical spectrum of El Hayek-Chahrour neurodevelopmental disorder (OMIM #620820), specifically highlighting severe motor impairment and complex cardiac involvement, including major aortopulmonary collateral artery, as previously undescribed features of this condition. The non-significant decrease in expression suggests that pathogenicity may arise from altered protein function rather than transcript depletion. Our findings underscore the importance of exome sequencing in delineating phenotypic variability in rare neurodevelopmental syndromes.\n                  <\/jats:p>","DOI":"10.1038\/s10038-026-01506-6","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:32:41Z","timestamp":1787124761000},"page":"741-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and characterisation of a novel homozygous KDM5A variant associated with severe axial hypotonia, seizures, and cardiac anomalies"],"prefix":"10.1038","volume":"71","author":[{"given":"Serdar","family":"Bozlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuneyd","family":"Yavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Seflekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunay","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6622-5083","authenticated-orcid":false,"given":"Yunus Emre","family":"Arvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"1506_CR1","unstructured":"KDM5A lysine demethylase 5A [Homo sapiens (human)], https:\/\/www.ncbi.nlm.nih.gov\/gene\/5927 2016."},{"key":"1506_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2023.2268813","volume":"18","author":"A Kataria","year":"2023","unstructured":"Kataria A, Tyagi S. Domain architecture and protein\u2013protein interactions regulate KDM5A recruitment to the chromatin. Epigenetics. 2023;18:2268813. https:\/\/doi.org\/10.1080\/15592294.2023.2268813.","journal-title":"Epigenetics"},{"key":"1506_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.22088\/cjim.15.4.579","volume":"15","author":"M Sheikhi","year":"2024","unstructured":"Sheikhi M, et al. Prognostic importance of NUP98-rearrangements in acute myeloid leukemia: a systematic review and meta-analysis. Casp J Intern Med. 2024;15:579\u201388. https:\/\/doi.org\/10.22088\/cjim.15.4.579.","journal-title":"Casp J Intern Med"},{"key":"1506_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113855","volume":"226","author":"GJ Yang","year":"2021","unstructured":"Yang GJ, et al. Pharmacological inhibition of KDM5A for cancer treatment. Eur J Med Chem. 2021;226:113855. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113855.","journal-title":"Eur J Med Chem"},{"key":"1506_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-021-01041-1","volume":"14","author":"GJ Yang","year":"2021","unstructured":"Yang GJ, et al. The emerging role of KDM5A in human cancer. J Hematol Oncol. 2021;14:30. https:\/\/doi.org\/10.1186\/s13045-021-01041-1.","journal-title":"J Hematol Oncol"},{"key":"1506_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56883","volume":"9","author":"L El Hayek","year":"2020","unstructured":"El Hayek L, et al. KDM5A mutations identified in autism spectrum disorder using forward genetics. Elife. 2020;9:e56883.","journal-title":"Elife"},{"key":"1506_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mrrev.2014.05.001","volume":"762","author":"JN Miller","year":"2014","unstructured":"Miller JN, Pearce DA. Nonsense-mediated decay in genetic disease: friend or foe? Mutat Res Rev Mutat Res. 2014;762:52\u201364. https:\/\/doi.org\/10.1016\/j.mrrev.2014.05.001.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"1506_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112642","volume":"42","author":"AE Campbell","year":"2023","unstructured":"Campbell AE, et al. Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expression. Cell Rep. 2023;42:112642. https:\/\/doi.org\/10.1016\/j.celrep.2023.112642.","journal-title":"Cell Rep"},{"key":"1506_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10423","volume":"478","author":"H Najmabadi","year":"2011","unstructured":"Najmabadi H, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478:57\u201363. https:\/\/doi.org\/10.1038\/nature10423.","journal-title":"Nature"},{"key":"1506_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.gene.2014.02.058","volume":"542","author":"IM Silva","year":"2014","unstructured":"Silva IM, Rosenfeld J, Antoniuk SA, Raskin S, Sotomaior VS. A 1.5Mb terminal deletion of 12p associated with autism spectrum disorder. Gene. 2014;542:83\u201386. https:\/\/doi.org\/10.1016\/j.gene.2014.02.058.","journal-title":"Gene"},{"key":"1506_CR11","doi-asserted-by":"publisher","unstructured":"Han JY, Park J. Variable phenotypes of epilepsy, intellectual disability, and schizophrenia caused BY 12p13.33-p13.32 Terminal microdeletion in a Korean family: a case report and literature review. Genes. 2021;12. https:\/\/doi.org\/10.3390\/genes12071001","DOI":"10.3390\/genes12071001"},{"key":"1506_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.117.001978","volume":"11","author":"JO Szot","year":"2018","unstructured":"Szot JO, et al. A screening approach to identify clinically actionable variants causing congenital heart disease in exome data. Circ Genom Precis Med. 2018;11:e001978. https:\/\/doi.org\/10.1161\/CIRCGEN.117.001978.","journal-title":"Circ Genom Precis Med"},{"key":"1506_CR13","doi-asserted-by":"publisher","unstructured":"El Hayek, L et al. KDM5A mutations identified in autism spectrum disorder using forward genetics. Elife. 2020;9. https:\/\/doi.org\/10.7554\/eLife.56883","DOI":"10.7554\/eLife.56883"},{"key":"1506_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112314","volume":"396","author":"R Kirtana","year":"2020","unstructured":"Kirtana R, Manna S, Patra SK. Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease. Exp Cell Res. 2020;396:112314. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112314.","journal-title":"Exp Cell Res"},{"key":"1506_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi0074","volume":"9","author":"L El Hayek","year":"2023","unstructured":"El Hayek L, et al. Disruption of the autism gene and chromatin regulator KDM5A alters hippocampal cell identity. Sci Adv. 2023;9:eadi0074. https:\/\/doi.org\/10.1126\/sciadv.adi0074.","journal-title":"Sci Adv"},{"key":"1506_CR16","doi-asserted-by":"publisher","unstructured":"El Hayek, L et al. Monoallelic and biallelic KDM5A variants identified in patients with autism spectrum disorder. Human Genetics Genom Adv. 2026;7:100594. https:\/\/doi.org\/10.1016\/j.xhgg.2026.100594.","DOI":"10.1016\/j.xhgg.2026.100594"},{"key":"1506_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajhg.2017.11.013","volume":"102","author":"V Faundes","year":"2018","unstructured":"Faundes V, et al. Histone lysine methylases and demethylases in the landscape of human developmental disorders. Am J Hum Genet. 2018;102:175\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.11.013.","journal-title":"Am J Hum Genet"},{"key":"1506_CR18","doi-asserted-by":"publisher","unstructured":"Lebon, S et al. Agenesis of the corpus callosum with facial dysmorphism and intellectual disability in sibs associated with compound heterozygous KDM5B variants. Genes. 2021;12. https:\/\/doi.org\/10.3390\/genes12091397","DOI":"10.3390\/genes12091397"},{"key":"1506_CR19","doi-asserted-by":"publisher","unstructured":"Borroto, MC et al. A genotype\/phenotype study of KDM5B-associated disorders suggests a pathogenic effect of dominantly inherited missense variants. Genes. 2024;15. https:\/\/doi.org\/10.3390\/genes15081033","DOI":"10.3390\/genes15081033"},{"key":"1506_CR20","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000646","volume":"8","author":"PM Wu","year":"2022","unstructured":"Wu PM, et al. Novel variations in the KDM5C gene causing X-linked intellectual disability. Neurol Genet. 2022;8:e646. https:\/\/doi.org\/10.1212\/NXG.0000000000000646.","journal-title":"Neurol Genet"},{"key":"1506_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02380-9","volume":"21","author":"NC Lippa","year":"2021","unstructured":"Lippa NC, Barua S, Aggarwal V, Pereira E, Bain JM. A novel de novo KDM5C variant in a female with global developmental delay and ataxia: a case report. BMC Neurol. 2021;21:358. https:\/\/doi.org\/10.1186\/s12883-021-02380-9.","journal-title":"BMC Neurol"},{"key":"1506_CR22","doi-asserted-by":"publisher","unstructured":"Terry, BK, Mahoney, A, Lee, BI, Secombe, J. Individuals with reported and novel KDM5C variants present with seizures, a feature recapitulated in a Drosophila model. Hum Mol Genet. 2026;15. https:\/\/doi.org\/10.1093\/hmg\/ddag001","DOI":"10.1093\/hmg\/ddag001"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01506-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:01:35Z","timestamp":1792879295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1038\/s10038-026-01506-6","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with the ethical standards outlined in the \u2018Declaration of Helsinki\u2019. The local ethics committee approved the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}